GLMD icon

Galmed Pharmaceuticals

17 hedge funds and large institutions have $5.39M invested in Galmed Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
17
Holders Change
-2
Holders Change %
-10.53%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
7
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
6CM
1
683 Capital Management
New York
$1.55M 268,000 +19,200 +8%
PWAM
2
Park West Asset Management
California
$1.17M 201,848
DCM
3
DAFNA Capital Management
California
$917K 158,121 +41,134 +35%
PA
4
Perceptive Advisors
New York
$435K 75,000
KCM
5
Knoll Capital Management
Florida
$377K 65,000
Goldman Sachs
6
Goldman Sachs
New York
$273K 47,119 +33,500 +246%
SKK
7
Shepherd Kaplan Krochuk
Massachusetts
$217K 37,380
Morgan Stanley
8
Morgan Stanley
New York
$140K 24,100 +10,033 +71%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$115K 19,955 +138 +0.7%
CA
10
CapWealth Advisors
Tennessee
$58K 10,000 +8,000 +400%
SIM
11
Spark Investment Management
New York
$57K 10,100 +10,100 New
BIT
12
BlackRock Institutional Trust
California
$45K 7,780 +5,053 +185%
Wells Fargo
13
Wells Fargo
California
$14K 2,414 -116,367 -98%
UBS Group
14
UBS Group
Switzerland
$9K 1,606 +1,606 New
TRCT
15
Tower Research Capital (TRC)
New York
$8K 1,294 +1,294 New
Bank of America
16
Bank of America
North Carolina
$3K 460
VAM
17
Visium Asset Management
New York
-154,773 Closed
PRCM
18
Pine River Capital Management
Minnesota
-79,020 Closed
EMG
19
Ellington Management Group
Connecticut
-11,200 Closed
BA
20
BlackRock Advisors
Delaware
-953 Closed
Citigroup
21
Citigroup
New York
$0 81 -675 -89%